Research advances in associations between IL28B polymorphisms and chronic hepatitis B /C virus infection

Shen WenJuan; Ha MingHao

doi:10.3969/j.issn.1001-5256.2014.10.028

Issue 10

Oct. 2014

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2014 > 30(10): 1087-1090

PDF( 1350 KB)

Research advances in associations between IL28B polymorphisms and chronic hepatitis B /C virus infection

DOI: 10.3969/j.issn.1001-5256.2014.10.028

Department of Infectious Diseases, Shanghai Seventh People's Hospital

Research funding:

Received Date: 2014-03-21
Published Date: 2014-10-20

Abstract

Abstract

Chronic infection with hepatitis B/C virus ( HBV/HCV) is a widespread epidemic in China. The single nucleotide polymorphisms ( SNPs) in interleukin 28B ( IL28B) gene have been associated with chronic HBV/HCV infection and response to interferon therapy. The biological functions and characteristics of IL28 B are elaborated on, the associations between HCV infection and IL28 B SNPs are commented on, and current reports of associations between HBV infection and IL28 B SNPs are reviewed. The results support the associations between IL28 B SNPs and disease progression of HCV infection or the curative effect of interferon therapy. However, contradictive results have been obtained in studies of associations between IL28 B SNPs and disease progression of HBV infection, the incidence of liver cirrhosis and primary liver cancer after HBV infection, or the curative effect of interferon therapy, so further investigation is needed.
- hepatitis B,
- hepatitis C,
- interleukins,
- polymorphism, single nucleotide,
- review

FullText(HTML)

References(36)

References

[1]GANEM D, PRINCE AM.Hepatitis B virus infection--naturat history and clinical consequences[J].N Engl J Med, 2004, 350 (11) :1118-1129.

[2]World Health Organization.Hepatitis B[EB/OL]. (2008-08) [2010-12-09]http//www.who.int/mediacentre/factsheets/fs204/en/.

[3]LIANG X, BI S, YANG W, et al.Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaceination[J].Vaccine, 2009, 27 (47) :6550-6557.

[4]LIANG X, BI S, YANG W, et al.Evaluation of the impact of hepatitis B vaccination among children bom during 1992-2005 in China[J].J Infect Dis, 2009, 200 (1) :39-47.

[5] LU FM, ZHUANG H.Management of hepatifis B in China[J].Chin Med J (Engl) , 2009, 122 (1) :3-4.

[6] Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B (2010 version) [J].J Clin Hepatol, 2011, 27 (1) :Ⅰ-ⅩⅥ. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南2010年版[J].临床肝胆病杂志, 2011, 27 (1) :Ⅰ-ⅩⅥ.

[7]YANG M, RAO HY.Key points of the AASLD's guidelines on hepatitis C diagnosis and treatment[J].J Clin Hepatol, 2013, 29 (2) :9-14. (in Chinese) 杨明, 饶慧瑛.美国肝病学会丙型肝炎诊治指南要点[J].临床肝胆病杂志, 2013, 29 (2) :9-14.

[8]KETENKO SV, GALLAGHER G, BAURIN VV, et al.IFN-lambads mediate antiviral protection through a distinct class II cytokine receptor complex[J].Nat Immunol, 2003, 4 (1) :69-77.

[9]UZG, MONNERON D.IL-28 and IL-29:newcomers to the interferon family[J].Biochimie, 2007, 89 (6-7) :729-734.

[10]ANK N, WEST H, PALUDAN SR.IFN-lambda:novel antiviral cytokine[J].J Interferon Cytokine Res, 2006, 26 (6) :373-379.

[11]O'BRIEN TR.Interferon-alfa, Interferon-lambda and hepatitis C[J].Nat Genet, 2009, 41 (10) :1048-1050.

[12]IADONATO SP, KAEZE MG.Genomics:Hepatitis C virus gets personal[J].Nature, 2009, 461 (7262) :357-358.

[13]THOMAS DL, THIO CL, MARTIN MP, et al.Genetic variation in IL28B and spontaneous clearance of hepatitis C virus[J].Nature, 2009, 461 (7265) :798-801.

[14]GE D, FELLAY J, THOMPSON AJ, et al.Genetic variation in IL28B predicts hepatitis C treatment—induced viral clearance[J].Nature, 2009, 461 (7262) :399-401.

[15]RAUCH A, KUTALILC Z, DESCOMBES P, et al.Genetic Variation in IL28B is associated with chronic hepatitis C and treatment failure:a genome-wide associationstudy[J].Gastroentemlogy, 2010, 138 (4) :1338-1345.

[16]MANGIA A, THOMPSON A, SANTORO R, et al.An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3patients who do not achieve a rapid virologic response[J].Gastroenterology, 2010, 139 (3) :821-827.

[17]MCCARTHY JJ, LI JH, THOMPSON A, et al.Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin[J].Gastroenterology, 2010, 138 (7) :2307-2314.

[18]REMBECK K, ALSIA, CHRISTENSEN PB, et al.Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3[J].PLoS One, 2012, 7 (1) :e29370.

[19]JACOBSON IM, MCHUTCHISON JG, DUSHEIKO G, et al.Telaprevir for previously untreated chronic hepatitis C virus infection[J].N Engl J Med, 2011, 364 (25) :2405-2416.

[20]HONDA M, SAKAI A, YAMASHITA A, et al.Hepatic ISG exprsssion is associated with genetic variation in interleukin 28B and the outcome of interferon therapy for chronic hepatitis C[J].Gastroenterology, 2010, 139 (2) :499-509.

[21]URBAN TJ, THOMPSON AJ, BRADRICK SS, et al.IL28B genotype is associated with differential expression of intrahepatic interferon, stimulated genes in patients with chronic hepatitis C[J].Hepatology, 2010, 52 (6) :1888-1896.

[22]SAITO H, ITO K, SUGIYAMA M, et al.Factors responsible for the discrepancy between IL28B polymorphism prediction and the viral response to peginterferon plus ribavirin therapy in Japanese chronic hepatitis C patients[J].Hepatol Res, 2012, 42 (10) :958-965.

[23]BOCHUD PY, BIBERT S, KUTALIK Z, et al.IL28B alleles associated with poor Hepatitis C clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes[J].Hepatology, 2012, 55 (2) :384-394.

[24]MARABITA F, AGHEMO A, DE NICOLA S, et al.Genetic variation in the interleukin-28B gene is not associated with fibrosisi progression in patients with chronic hepatitis C and known date of infection[J].Hepatology, 2011, 54 (4) :1127-1134.

[25]AL-QAHTANI AA, AL-ANAZI MR, ABDO AA, et al.Genetic variation in interleukin 28 B and correlation with chronic hepatitis B virus infection in Saudi Arabian patients[J].Liver Int, 2014, 34 (7) :e208-e216.

[26]CHENG L, SUN X, TAN S, et al.Effect of HLA-DP and IL28B gene polymorphisms on response to interferon treatment in hepatitis B e-antigen seropositive chronic hepatitis B patients[J].Hepatol Res, 2014, 44 (9) :1000-1007.

[27]ZHANG Q, LAPALUS M, ASSELAH T, et al.IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients[J].J Virol Hepat, 2014, 21 (7) :525-532.

[28]CHEN J, WANG L, LI Y, et al.Association analysis between SNPs in IL-28B gene and the progress of hepatitis B infection in Han Chinese[J].PLoS One, 2012, 7 (12) :e50787.

[29]LEE IC, LIN CH, HUANG YH, et al.IL28B polymorphism correlates with active hepatitis in patients with HBeAg-negative chronic hepatitis B[J].PLoS One, 2013, 8 (2) :e58071.

[30]TAMORI A, KAWADA N.HLA classⅡassociated with outcomes of hepatitis B and C infections[J].World J Gastroenterol, 2013, 19 (33) :5395-5401.

[31]KIM SU, SONG KJ, CHANG HY, et al.Association between IL28B Polymorphisms and spontaneous clearance of hepatitis B virus infection[J].PLoS One, 2013, 8 (7) :e69166.

[32]GARCIA-SAMANIEGO J, ROMERO M, GRANADOS R, et al.Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C[J].World J Gastroenterol, 2013, 19 (12) :1943-1952.

[33]LI W, JIANG Y, JIN Q, et al.Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population[J].Liver Int, 2011, 31 (8) :1118-1126.

[34]MARTIN MP, QI Y, GOEDERT JJ, et al.IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection[J].J Infect Dis, 2012, 202 (11) :1749-1753.

[35]LAMPERTICO P, VIGANOM, CHERONI C, et al.IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B[J].Hepatology, 2013, 57 (3) :890-896.

[36]SONNEVELD MJ, WONG VW, WOLTMAN AM, et al.Polymorphisms near IL28B and serologic response to peginterferon in HbeAg positive patients with chronic hepatitis B[J].Gastroenterology, 2012, 142 (2) :513-520.

Relative Articles

[1]	Zhang Qing, Liu ShouSheng, Sun BaoKai, Zhang Mei, Xin YongNing. Association of peroxisome proliferator-activated receptor gamma coactivator 1 alpha rs8192678 single nucleotide polymorphism with the risk of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(9): 2035-2039. doi: 10.3969/j.issn.1001-5256.2020.09.025
[2]	Ren Shan, Du XiaoFei, Huang YunLi, Huang ChunYang, Zhang XiaoDan, Dan Jing, Chen XinYue. Serum interferon-gamma-induced protein-10 level and gene polymorphism in patients with drug-induced liver injury accompanied by autoimmune phenomena[J]. Journal of Clinical Hepatology, 2020, 36(3): 602-607. doi: 10.3969/j.issn.1001-5256.2020.03.026
[3]	Liu Qun, Luan GuiPing, Gao Hui, Zhao BenTian, Du ShuiXian, Liu ShouSheng, Xin YongNing. Association of TRIB1 rs2954029 single nucleotide polymorphism with the risk of nonalcoholic fatty liver disease and coronary heart disease[J]. Journal of Clinical Hepatology, 2019, 35(6): 1330-1336. doi: 10.3969/j.issn.1001-5256.2019.06.030
[4]	Ou WeiJie, Lin YeHong, Zhou Qing, Shang TianYu, Lin Su, Zhu YueYong. Association of vitamin D-related gene polymorphisms with hepatitis B virus-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2019, 35(6): 1308-1312. doi: 10.3969/j.issn.1001-5256.2019.06.025
[5]	Zhang YanBing, Ding YouMing. Research advances in polymorphisms of pancreatitis-associated genes[J]. Journal of Clinical Hepatology, 2018, 34(3): 667-671. doi: 10.3969/j.issn.1001-5256.2018.03.051
[6]	Ran XiaoJuan, Yang Jing. Association between estrogen receptor gene polymorphisms and the development and progression of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2018, 34(2): 429-432. doi: 10.3969/j.issn.1001-5256.2018.02.047
[7]	Liao SongLing, Liu ShouSheng, Wang Cong, Chen LiZhen, Xin YongNing, Xuan ShiYing. Association between MBOAT7 rs641738 polymorphism and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2018, 34(10): 2169-2174. doi: 10.3969/j.issn.1001-5256.2018.10.021
[8]	Yue HaiYan, Liu ShouSheng, Wang Cong, Gu JiuLian, Xin YongNing, Xuan ShiYing. Association between single nucleotide polymorphism of low-density lipoprotein receptor and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2018, 34(9): 1929-1935. doi: 10.3969/j.issn.1001-5256.2018.09.021
[9]	Zhang Hua, He DeHua, Li GuiZhong. Association between single nucleotide polymorphism of microRNA-146a and recurrence after liver cancer surgery[J]. Journal of Clinical Hepatology, 2016, 32(5): 904-907. doi: 10.3969/j.issn.1001-5256.2016.05.018
[10]	Wang Wei, Zhao RongRong, Yang XiaoFei, Huang ZhangXing, Lian JianQi, Wang JiuPing, Zhang Ye. Influence of Notch signaling pathway on interleukin-22 secreted by CD4~+T cells in patients with hepatitis B[J]. Journal of Clinical Hepatology, 2016, 32(7): 1315-1318. doi: 10.3969/j.issn.1001-5256.2016.07.020
[11]	Zhu DuanQuan, Wu Hao, Gong JianPing. Gene polymorphisms in non-alcoholic fatty liver disease: a review of research progress[J]. Journal of Clinical Hepatology, 2015, 31(7): 1163-1167. doi: 10.3969/j.issn.1001-5256.2015.07.042
[12]	Lu Ying. Correlation of serum interleukin-33 with HBV DNA load and ALT level in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2015, 31(11): 1853-1856. doi: 10.3969/j.issn.1001-5256.2015.11.020
[13]	Mao YiJia, Mao XiaoRong, Jiang Ni. Recent research on association between gene polymorphisms of IL-28B and other cytokines and HCV infection[J]. Journal of Clinical Hepatology, 2015, 31(8): 1347-1350. doi: 10.3969/j.issn.1001-5256.2015.08.044
[14]	Zhang Can, Wan Hui, Chen Hong, Zhang Kai. Research progress in interleukin 28B polymorphisms in infection and treatment of chronic hepatitis B virus[J]. Journal of Clinical Hepatology, 2015, 31(4): 622-625. doi: 10.3969/j.issn.1001-5256.2015.04.036
[15]	Li Long, Wu ZhangHui, Wei Jia. Research progress in association between interleukin 28B gene polymorphism and hepatitis B[J]. Journal of Clinical Hepatology, 2015, 31(11): 1916-1920. doi: 10.3969/j.issn.1001-5256.2015.11.040
[16]	Tan GuoLei, Sun Mei, Wang JianFang, Wu XuPing. Relationship between IL- 28B polymorphisms and susceptibility to hepatitis C among Han population in Jiangsu Province, China[J]. Journal of Clinical Hepatology, 2014, 30(6): 514-517. doi: 10.3969/j.issn.1001-5256.2014.06.009
[17]	Zhou Li, Qie ChunHua, Guo Jie, Lu Wei, Wang Yi, Gao Min, Lu ChengZhen, Han Xu, Zhai Lu. Association between the type Ⅰinterferon receptor promoter gene and treatment response to antivirus in patients with chronic hepatitis C[J]. Journal of Clinical Hepatology, 2012, 28(5): 352-355.
[18]	Chen HuiJuan, Zhao ShouSong. Recent insights into the roles of regulatory T cells in viral hepatitis[J]. Journal of Clinical Hepatology, 2012, 28(11): 868-871.
[19]	Zuo WeiZe, Xu ChunMei, Shen LanChao. Changes in serum level of interleukin-32 and interleukin-6 in patients with chronic hepatitis B virus infection and its clinical significance[J]. Journal of Clinical Hepatology, 2011, 27(4): 408-410+413.
[20]	Shi XiaoDong, Jiang Jing, Niu JunQi. Association of interleukin 28B(IL28B) polymorphisms with the outcomes of HCV infection[J]. Journal of Clinical Hepatology, 2011, 27(1): 28-31.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2665) PDF downloads(574)

Research advances in associations between IL28B polymorphisms and chronic hepatitis B /C virus infection

DOI: 10.3969/j.issn.1001-5256.2014.10.028

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Research advances in associations between IL28B polymorphisms and chronic hepatitis B /C virus infection

DOI: 10.3969/j.issn.1001-5256.2014.10.028

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content